Vaxelis (DTaP-IPV-Hib-HepB 6-in-1)

Approved for VAXELIS ® is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae ( H. influenzae ) type b. VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).. Diphtheria Diphtheria is an acute toxin-mediated disease…

Loading full data from Know Your Drugs Institute…